A bstract. The in vitro regulation of adult human monocyte DR antigen expression was studied. Normally about 75% of freshly obtained human peripheral blood monocytes express DR antigens as determined by anti-DR and complement-mediated cytotoxicity assays. DR expression on monocytes in unfractionated peripheral blood mononuclear cell cultures persisted to variable degrees for up to 5 d of incubation. However, when the mononuclear cells were thoroughly depleted of nonadherent cells, cultured monocytes consistently exhibited progressively decreased DR expression over 2-5 d of incubation. Readdition of nonadherent cells to the adherent cell population prevented or delayed this decrease in monocyte DR antigen expression. Thus, monocyte DR expression diminished markedly during in vitro incubation; however, the presence of nonadherent cells somehow interfered with this process. In other experiments, peripheral adherent monocytes, which had been cultured for 2-3 d to reduce their DR expression, could be induced to reexpress
Introduction
The initiation ofantigen-specific, T-dependent human immune responses in vitro requires the participation of accessory cells that express DR antigens. We have investigated factors that regulate the DR antigen expression on human monocytes, a principal class of accessory cells (1, 2) . Studies of the in vitro regulation of murine macrophage Ia antigen expression, the homologue of DR antigens (3, 4) , have revealed that crude lymphokine-containing culture supernatant (lymphokine) induces macrophage Ia antigen expression (5, 6) and accessory cell function (6) (7) (8) in vitro. Biochemical analysis of such supernatants has indicated that the active lymphokine is similar, ifnot identical, to recombinant human gamma interferon (IFN- y)' (9) . Furthermore, three conditions were identified which favored reversion of macrophages to the la-state: the absence of lymphokine preparations containing interferon (IFN) (10) , corticosteroid treatment (I 1), and prostaglandin or prostaglandin inducers (12) , all of which also inhibited the induction of macrophage Ia antigen expression even in the presence of partially purified IFN-'y.
With regard to man, Yem and Parmely (13) have reported that bacterial endotoxin and zymozan A both inhibited peripheral blood monocyte DR antigen expression and accessory cell function in vitro. However, their study did not reveal any positive immunoregulatory signals. We have shown that both lymphokines and recombinant IFN-a (IFLrA, IFLrD) can augment the normally low DR expression of human cord blood monocytes (14) . Dayton et al. (15) Anti-human IFN-y antiserum. Rabbit antiserum to a synthetic peptide corresponding to the first 20 N-terminal amino acids of human IFN--y based on cDNA sequence was prepared as described (19) , and was added to the cultures in the concentrations indicated. 1 The sensitivity of this assay has a CI of 5%, and its precision is 6.3%. In experiments using the promyelocytic cell line HL60 as target cells for DR antigen induction, the cytotoxicity assay as described directly correlated (r2 = 0.945) with FACS analysis by using the same antiserum.2 Additionally, this assay has been extensively used in the murine system (6, 9) for detection of Ia antigens on macrophages. Accessory cell capacity ofperipheral blood monocytes in the mixed lymphocyte response (MLR). Graded numbers of peripheral blood monocytes were isolated, incubated for 3 d, treated with p23,30 anti-DR heteroantiserum and complement to eliminate any remaining DR' cells, and subsequently cultured for 2 d with 0.2 ml/well of medium containing maximally active dilutions of either Con A-stimulated culture supernatant (1:5), IFLrA (30 U/ml), or a corresponding dilution of a control culture supernatant. At this time, the % DR' cells was determined in a replicate culture. The culture supernatant of the remaining cultures were removed, each well carefully washed once with 100 Al of RPMI 1640, and 2-4 X 105 histoincompatible responder lymphocytes in 200 1 l media were added to each well. The responder cells were isolated from PBMNC after two incubations (one lasting overnight, and the subsequent one for 1 h) on plastic flasks to remove adherent cells, followed by nylon-wool column elution to remove residual adherent cells, and finally a treatment with anti-DR (1:100 dilution) and complement (1:10 dilution). Less than 0.5% of the resulting cell population stained with nonspecific esterase. Cocultures of peripheral blood monocytes and responder lymphocytes were incubated with or without a 1:20 dilution of p23,30 anti-DR serum at 37°C in a humidified atmosphere of 5% CO2 in air. After 2 d of incubation, the supernatants of one set of cultures were harvested and tested for IL-2 activity; the remaining set of cocultures were incubated for two additional days, incubated overnight with 0.5 ACi 3H-thymidine/well (New England Nuclear, Boston, MA), and harvested, and the radioactivity was determined by liquid scintillation counting.
Results
Effect of in vitro incubation on peripheral blood monocyte DR antigen expression. Thoroughly washed adherent PBMNC, which were 95-99% monocytes as determined by nonspecific esterase staining, were incubated for 1-4 d in medium, and the percentage of DR+ cells determined daily (Fig. 1) . 70-85% of freshly obtained peripheral blood monocytes was DR+, as determined by complement-mediated cytotoxicity using anti-DR (p23,30) heteroantiserum. In a similar system, using the HL60 promyelocytic cell line, the DR antigen detection by the complement-mediated cytotoxicity assay by using the same antiserum directly correlated with those obtained by FACS analysis,2 substantiating the accuracy of the assay used in this study. The DR antigen expression of cultured monocytes declined with time in culture, although the rate and extent of this decline varied from subject to subject. In 83% of the experiments (15:18), the percentage of DR' cells, as determined by anti-DR and complement-mediated cytotoxicity, progressively declined to <45% by days 2-3 and plateaued at that level ( Fig. 1 A, C, D) . In 3 of 18 experiments, however, the percentage of DR' cells decreased to only 45-65% range by days 2 through 4 of culture (Fig. 1 B) . In parallel experiments, HLA-A, B, C antigen expression, which is present in about 80-95% of freshly isolated adherent PBMNC, did not decline with time in culture (data not shown). The addition of 1 Ag/ml polymyxin B to these cultures did not significantly alter the rate ofloss ofDR antigen expression (Fig. 1 D) (Fig. 1 B, C Fig. 2 ., right panel, lymphokines induced elevated percentages ofthe cultured DR antigen-deficient (DR-) monocytes to express DR antigens, indicating that lymphokines are able to induce DR antigen expression in a DR-population. (Fig. 6) , increased concentrations of anti-IFN-'y antiserum accelerated the rate of decline of monocyte expression of DR in a dosedependent fashion, while normal rabbit serum had no significant effect. In contrast, HLA-A,B,C antigen expression was not affected by these treatments (data not shown). These data, when taken together with the observation that addition of autologous nonadherent cells maintained or delayed loss of DR antigen expression by peripheral blood monocytes, suggest that lymphocyte-derived IFN-y may be playing an important role in the maintenance of the monocyte DR phenotype.
Accessory cell capabilities of lymphokine/IFN-cultured monocytes in the MLR. In order to evaluate the MLR-inducing activity of the IFN-treated monocytes, graded numbers of adherent PBMNC pretreated with p23,30 anti-DR heteroantiserum and complement were preincubated with maximally active dilutions of either lymphokines, IFLrA, or IFLrD, and subsequently were washed and cocultured with histoincompatible purified responder lymphocytes. Lymphocyte activation was evaluated both by proliferation and IL-2 production ( Table I) . As shown, monocytes incubated with lymphokines or recombinant IFN-a stimulated a significant and dose-dependent IL-2 production (up to 23 U/ml) and proliferation by allogeneic lymphocytes (P < 0.02 and P < 0.05, respectively) as compared with the IL-2 production and proliferation induced by monocytes incubated in medium alone. Both responses were abrogated by adding anti-DR to the cultures, suggesting the DR antigen-dependency of the MLR. The ability of lymphokine/IFN-a incubated monocytes to activate histoincompatible lymphocytes to produce IL-2 was greater than the proliferative response. Control cultured monocytes stimulated <6 U/ml of IL-2 production and no proliferation.
Discussion
Recently, much attention has been focused on the fact that IFN might regulate the expression of histocompatibility antigens in several cell types (24) (25) (26) (27) (28) . Macrophage expression of the Class II molecules of the major histocompatibility complex has been studied in the mouse (Ta antigens) and in man (DR antigens).
It has been reported that murine splenic macrophages become Ia-during in vitro incubation (29) . Yem and Parmely (13) have indicated that human peripheral blood monocyte DR antigen expression is stable in culture. In contrast, we report here that human peripheral blood monocytes, cultured in the absence of exogenous signals, express progressively less DR antigen. A possible explanation for this discrepancy is that endogenous lymphokine production by contaminating nonadherent or weakly adherent cells apparently can maintain monocyte DR antigen expression. Indeed, only when the monocytes used in this study were vigorously washed six to eight times before culture did their DR expression consistently diminish. Furthermore, addition of autologous nonadherent cells to monocyte cultures led to a maintenance of DR antigen expression in vitro, suggesting that contaminating lymphocytes were responsible for the sustained DR expression in vitro in the studies reported by Yem and Parmely (13).
The decrease of human monocyte DR antigen expression in vitro can be accelerated by the addition of a highly specific antiserum directed against a synthetic peptide corresponding to the N-terminus of IFN-y even in the presence of contaminating lymphocytes, suggesting that lymphocyte-derived IFN-y is playing an important role in sustaining DR antigen expression in vitro. This finding also suggests that resting normal peripheral blood lymphocytes must spontaneously secrete low levels of IFN-'y in vitro. Perhaps, endogenous production of IFN-y in the individual also accounts for the high percentage of DR' monocytes found in adult blood.
The fact that an antiserum against human IFN-'y significantly blocked lymphokine enhancement of DR' expression by monocytes indicates that IFN-,y is at least one of the active mediators in the lymphokine supernatant. This conclusion is strongly supported by the observed direct effect of recombinant human IFN on the induction of DR expression by monocytes, and the evidence that recombinant IFN-y was more potent in inducing DR antigen expression than either of two species of IFN-a in terms of both maximal response elicited, and that fewer units of antiviral activity were needed to induce a maximal response. It should be noted that these experiments do not completely eliminate the possibilities that lymphokines other than IFN may have monocyte DR antigen modulatory activity, or that other lymphokines can synergistically enhance IFN induction of monocyte DR antigen expression. The possibility that contaminating cell types present in peripheral blood monocyte cultures contribute to the enhancement of DR antigen expression is unlikely since in experiments using the homogeneous cloned human promyelocytic cell line HL60, both supernatant lymphokines and recombinant IFN sufficed to enhance DR antigen expression2.
The functional concomitant of DR antigen expression in monocytes was studied by assessing their ability to stimulate MLR. Lymphokine/IFN-a preincubated monocytes could stimulate an MLR, as indicated by IL-2 production and histoincompatible lymphocyte proliferation. However, several questions remain unanswered. First, it is unclear why, in the presence of significant IL-2 production, there was only modest, however significant, lymphocyte proliferation. As recently suggested, it is possible that macrophages are less effective than other cell types as alloantigen-presenting accessory cells (30, 31 (32, 33) and mice (34, 35) . Neonatal immunodeficient mice also exhibit low Ia antigen expression in spleen macrophages (35) . Human cord blood monocytes have also been found to express fewer DR antigens than adult monocytes (14, 36 (37, 38) . Treatment of both of the latter strains of mice with prostaglandins, which have been shown to inhibit the IFN-y induction of macrophage Ia antigen expression (10) , resulted in both a decline in macrophage Ia antigen expression (43) . Presumably, the capacity to induce immunological reactions varies with DR expression, but the physiological role and contribution of this phenomenon to disease states remain to be established.
